The German pharmaceutical group behind one of the most successful COVID-19 vaccines wants to use the same technology to develop a malaria vaccine.
BioNTech, who developed the first coronavirus jab with US company Pfizer, is aiming to begin clinical trials for a “safe and highly effective malaria vaccine” by the end of next year.
Array
